1 |
Andre C, Perrin-Fayolle M, Grosclaude M, et al. A double- blind placebo-controlled evaluation of sublingual immunotherapy with a standardized ragweed extract in patients with seasonal rhinitis: evidence for a dose-response relationship. Int Arch Allergy Immunol 2003;131:111‐118.
DOI
ScienceOn
|
2 |
Bowen T, Greenbaum J, Charbonneau Y, et al. Canadian trial of sublingual swallow immunotherapy for ragweed rhinoconjunctivitis. Ann Allergy Asthma Immunol 2004; 93:425-430.
DOI
ScienceOn
|
3 |
Chang TW, Shiung YY. Anti-IgE as a mast cell-stabilizing therapeutic agent. J Allergy Clin Immunol 2006;117: 1203-1212.
DOI
ScienceOn
|
4 |
Holgate S, Casale T, Wenzel S, Bousquet J, Deniz Y, Reisner C. The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation. J Allergy Clin Immunol 2005;115:459-465.
DOI
ScienceOn
|
5 |
Kopp MV. Omalizumab: anti-IgE therapy in allergy. Curr Allergy Asthma Rep 2011;11:101-106.
DOI
ScienceOn
|
6 |
National guideline for the management of asthma. J Asthma Allergy Clin Immunol 1998;18:339-384.
|
7 |
Kim TB, Kim KM, Kim SH, et al. Sensitization rates for inhalant allergens in Korea; a multi-center study. J Asthma Allergy Clin Immunol 2003;23:483-493.
|
8 |
Hur GY, Lee HY, Choi GS, et al. Clinical features of patients in remission after house dust mite allergen immunotherapy in adult asthma. Korean J Asthma Allergy Clin Immunol 2007;27:257-262.
|
9 |
Lim SB, Park IY, Lee KY, Hong CS. Study on allergen of immunotherapy in allergic diseases. Korean J Asthma Allergy Clin Immunol 1988;8:138-149.
|
10 |
Adkinson NF Jr, Eggleston PA, Eney D, et al. A controlled trial of immunotherapy for asthma in allergic children. N Engl J Med 1997;336:324-331.
DOI
ScienceOn
|
11 |
Oh JW. Development of pollen concentration prediction models. J Korean Med Assoc 2009;52:579-591.
DOI
ScienceOn
|
12 |
Hur GY, Kim TB, Kim ST, et al. Allergy Immunotherapy. Korean J Asthma Allergy Clin Immunol 2010;30:153-183.
|
13 |
Dahl R, Kapp A, Colombo G, et al. Sublingual grass allergen tablet immunotherapy provides sustained clinical benefit with progressive immunologic changes over 2 years. J Allergy Clin Immunol 2008;121:512-518.e2.
DOI
ScienceOn
|
14 |
Dahl R, Kapp A, Colombo G, et al. Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006;118:434-440.
DOI
ScienceOn
|
15 |
Durham SR, Yang WH, Pedersen MR, Johansen N, Rak S. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006;117: 802-809.
DOI
ScienceOn
|
16 |
Gauvreau GM, Hessel EM, Boulet LP, Coffman RL, O'Byrne PM. Immunostimulatory sequences regulate interferon- inducible genes but not allergic airway response. Am J Respir Crit Care Med 2006;174:15-20.
DOI
ScienceOn
|
17 |
Wilson DR, Lima MT, Durham SR. Sublingual immunotherapy for allergic rhinitis: systematic review and metaanalysis. Allergy 2005;60:4-12.
DOI
ScienceOn
|
18 |
Roberts G, Xatzipsalti M, Borrego LM, et al. Paediatric rhinitis: position paper of the European Academy of Allergy and Clinical Immunology. Eur J Allergy Clin Immunol 2013;68:1102-1116.
|
19 |
Brozek JL, Bousquet J, Baena-Cagnani CE, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol 2010;126:466-476.
DOI
ScienceOn
|
20 |
Matsui EC. Role of environmental control in the management of asthma and allergy. J Allergy Clin Immunol 2012; 129:271.e1-3.
DOI
|
21 |
Weiner JM, Abramson MJ, Puy RM. Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials. BMJ 1998;317:1624-1629.
DOI
ScienceOn
|
22 |
Kelly HW, Sternberg AL, Lescher R, et al. Effect of inhaled glucocorticoids in childhood on adult height. N Engl J Med 2012;367:904-912.
DOI
ScienceOn
|
23 |
Schenkel EJ, Skoner DP, Bronsky EA, et al. Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray. Pediatrics 2000;105:E22.
DOI
ScienceOn
|
24 |
Mortuaire G, de Gabory L, François M, et al. Rebound congestion and rhinitis medicamentosa: nasal decongestants in clinical practice: critical review of the literature by a medical panel. Eur Ann Otorhinolaryngol Head Neck Dis 2013; 130:137-144.
DOI
ScienceOn
|
25 |
Bel EH. Clinical practice: mild asthma. N Engl J Med 2013;369:549-557.
DOI
ScienceOn
|
26 |
Meltzer EO, Berman GD, Corren J, et al. Addition of ibuprofen to pseudoephedrine and chlorpheniramine in the treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol 2004;93:452-459.
DOI
ScienceOn
|
27 |
Johnstone DE, Dutton A. The value of hyposensitization therapy for bronchial asthma in children: a 14-year study. Pediatrics 1968;42:793-802.
|
28 |
Pajno GB, Barberio G, De Luca F, Morabito L, Parmiani S. Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy: a six-year follow-up study. Clin Exp Allergy 2001;31:1392- 1397.
DOI
ScienceOn
|
29 |
Matsuno O, Miyazaki E, Takenaka R, et al. Links between bronchial asthma and allergic rhinitis in the Oita Prefecture, Japan. J Asthma 2006;43:165-167.
DOI
ScienceOn
|
30 |
Vignola AM, Chanez P, Godard P, Bousquet J. Relationships between rhinitis and asthma. Allergy 1998;53:833-839.
DOI
ScienceOn
|
31 |
Lundbäck B. Epidemiology of rhinitis and asthma. Clin Exp Allergy 1998;28(Suppl 2):3-10.
|
32 |
Bush RK. Does allergen avoidance work? Immunol Allergy Clin North Am 2011;31:493-507.
DOI
ScienceOn
|
33 |
Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, revised 2012. Available from: http://ginasthma.org/local/uploads/files/GINA_Report_Mar ch13.pdf.
|
34 |
Sheikh A, Hurwitz B, Shehata Y. House dust mite avoidance measures for perennial allergic rhinitis. Cochrane Database Syst Rev 2007;(1):CD001563.
|
35 |
Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008;63(Suppl 86):8-160.
DOI
ScienceOn
|
36 |
Jacobsen L, Nũchel Petersen B, Wihl JA, Løwenstein H, Ipsen H. Immunotherapy with partially purified and standardized tree pollen extracts: IV. results from long-term (6-year) follow-up. Allergy 1997;52:914-920.
DOI
ScienceOn
|
37 |
Kleine-Tebbe J, Ribel M, Herold DA. Safety of a SQ-standardised grass allergen tablet for sublingual immunotherapy: a randomized, placebo-controlled trial. Allergy 2006;61: 181-184.
DOI
ScienceOn
|